SCHEMBL2652477

SCHEMBL2652477

CCOC(=O)c1ccc(CCNNC(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
ESR1 P03372 1/20 0.57
CA7 P43166 1/20 0.57
CA9 Q16790 1/20 0.57
ESR2 Q92731 1/20 0.57
CA14 Q9ULX7 1/20 0.57
MAPT P10636 5/20 0.55
ALDH1A1 P00352 4/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
GAA P10253 2/20 0.55
ALOX12 P18054 1/20 0.55
LMNA P02545 2/20 0.53
POLB P06746 1/20 0.53
HTT P42858 2/20 0.52
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2652265 0.89 SMN1; SMN2 (0.59) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL4606214 0.88 SMN1; SMN2 (0.52) SMN1; SMN2CA12CA1CA2ESR1
SCHEMBL1054945 0.87 CYP4A11 (0.58) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL2654355 0.85 CA12 (0.48) SMN1; SMN2CA12CA1CA2ESR1
SCHEMBL3008746 0.84 SMN1; SMN2 (0.56) SMN1; SMN2CA12CA1CA2ESR1
SCHEMBL12199135 0.83 CA1 (0.68) SMN1; SMN2CA12CA1CA2ESR1
SCHEMBL2654326 0.83 LMNA (0.57) SMN1; SMN2CA12CA1CA2ESR1
SCHEMBL18224566 0.83 SMN1; SMN2 (0.59) SMN1; SMN2CA12CA1CA2ESR1
Hydrochloric Acid SCHEMBL2653365 0.81 LMNA (0.56) SMN1; SMN2CA12CA1CA2ESR1
SCHEMBL10765170 0.80 CYP4A11 (0.62) SMN1; SMN2CA12CA1CA2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773330-A4 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO INC (US) 2009-01-21 EP disclosed
EP-1940799-A1 PYRAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2008-07-09 EP disclosed
WO-2007047676-A1 PYRAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2007-04-26 WO disclosed
EP-1773330-A2 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2007-04-18 EP disclosed
EP-1756064-A2 PYRAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2007-02-28 EP disclosed
WO-2006014618-A2 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2006-02-09 WO disclosed
WO-2005121097-A2 PYRAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2005-12-22 WO disclosed